AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $291,948 | -49.6% | 648,053 | -67.6% | 0.00% | – |
| Q1 2023 | $579,303 | -35.5% | 1,997,597 | 0.0% | 0.00% | – |
| Q4 2022 | $898,719 | -9.5% | 1,997,597 | +5.8% | 0.00% | – |
| Q3 2022 | $993,000 | +0.9% | 1,887,396 | -3.1% | 0.00% | – |
| Q2 2022 | $984,000 | -79.8% | 1,948,009 | -8.0% | 0.00% | – |
| Q1 2022 | $4,869,000 | -51.7% | 2,117,323 | -0.2% | 0.00% | – |
| Q4 2021 | $10,073,000 | -39.9% | 2,120,625 | +0.6% | 0.00% | – |
| Q3 2021 | $16,765,000 | +14.9% | 2,108,760 | +0.6% | 0.00% | – |
| Q2 2021 | $14,596,000 | -15.2% | 2,097,166 | -3.5% | 0.00% | – |
| Q1 2021 | $17,219,000 | +12.1% | 2,174,062 | +11.4% | 0.00% | – |
| Q4 2020 | $15,356,000 | +17.1% | 1,951,224 | +5.5% | 0.00% | – |
| Q3 2020 | $13,112,000 | -23.2% | 1,849,454 | +0.2% | 0.00% | -100.0% |
| Q2 2020 | $17,071,000 | +209.4% | 1,845,496 | +55.8% | 0.00% | – |
| Q1 2020 | $5,518,000 | -38.8% | 1,184,306 | +0.4% | 0.00% | – |
| Q4 2019 | $9,016,000 | +3.8% | 1,180,164 | +4.5% | 0.00% | – |
| Q3 2019 | $8,684,000 | +14.8% | 1,129,248 | +2.2% | 0.00% | – |
| Q2 2019 | $7,567,000 | -15.3% | 1,104,698 | -0.5% | 0.00% | – |
| Q1 2019 | $8,937,000 | +53.0% | 1,110,212 | +42.3% | 0.00% | – |
| Q4 2018 | $5,843,000 | -18.9% | 780,204 | +3.6% | 0.00% | – |
| Q3 2018 | $7,207,000 | -2.4% | 753,031 | +7.9% | 0.00% | – |
| Q2 2018 | $7,383,000 | +120.6% | 697,838 | +106.8% | 0.00% | – |
| Q1 2018 | $3,347,000 | +128.2% | 337,423 | +24.4% | 0.00% | – |
| Q4 2017 | $1,467,000 | +93.0% | 271,252 | +69.1% | 0.00% | – |
| Q3 2017 | $760,000 | +31.3% | 160,385 | +6.4% | 0.00% | – |
| Q2 2017 | $579,000 | -43.6% | 150,774 | +9.4% | 0.00% | – |
| Q1 2017 | $1,027,000 | +329.7% | 137,808 | +150.8% | 0.00% | – |
| Q4 2016 | $239,000 | +154.3% | 54,958 | +275.5% | 0.00% | – |
| Q3 2016 | $94,000 | – | 14,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $258,000 | 3.49% |
| Aisling Capital Management LP | 1,691,151 | $3,890,000 | 2.10% |
| Sio Capital Management, LLC | 871,101 | $2,004,000 | 0.66% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $6,550,000 | 0.64% |
| Samsara BioCapital, LLC | 883,720 | $2,033,000 | 0.51% |
| Ghost Tree Capital, LLC | 686,599 | $1,579,000 | 0.34% |
| Nantahala Capital Management | 3,200,593 | $7,361,000 | 0.33% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $565,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $9,338,000 | 0.28% |
| Lion Point Capital, LP | 300,000 | $690,000 | 0.16% |